290 related articles for article (PubMed ID: 32871892)
1. Efficacy and safety of ACEI/ARB drugs in patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis of randomized controlled trials.
Yang Y; Liu X; Liu Y; Chen Y; Tian Y; Fu X; Zhong W; Xie C
Medicine (Baltimore); 2020 Aug; 99(35):e21723. PubMed ID: 32871892
[TBL] [Abstract][Full Text] [Related]
2. The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
Yang Y; Chen XFD; Chen Y; Xie H; Xie C; Ying L
Medicine (Baltimore); 2020 Oct; 99(44):e22587. PubMed ID: 33126305
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.
Li Y; Liu X; Guo L; Li J; Zhong D; Zhang Y; Clarke M; Jin R
Syst Rev; 2020 Apr; 9(1):75. PubMed ID: 32268923
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
Liu Y; Fu X; Xie C
Medicine (Baltimore); 2020 Sep; 99(37):e22031. PubMed ID: 32925737
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis.
Zhu Z; Zhang Q; Liu L; Bao P; Liu S; Song C; Yang W; Nan Z
Medicine (Baltimore); 2022 Dec; 101(49):e31490. PubMed ID: 36626537
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): A protocol for systematic review and meta analysis.
Liu D; You Y; Chen Y; Tang S
Medicine (Baltimore); 2020 Jul; 99(29):e20781. PubMed ID: 32702822
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
Rico-Mesa JS; White A; Anderson AS
Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
[TBL] [Abstract][Full Text] [Related]
8. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Pranata R; Permana H; Huang I; Lim MA; Soetedjo NNM; Supriyadi R; Soeroto AY; Alkatiri AA; Firman D; Lukito AA
Diabetes Metab Syndr; 2020; 14(5):983-990. PubMed ID: 32615377
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.
Bean DM; Kraljevic Z; Searle T; Bendayan R; Kevin O; Pickles A; Folarin A; Roguski L; Noor K; Shek A; Zakeri R; Shah AM; Teo JTH; Dobson RJB
Eur J Heart Fail; 2020 Jun; 22(6):967-974. PubMed ID: 32485082
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis.
Zhao J; Ai J; Mo C; Shi W; Meng L
Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481
[TBL] [Abstract][Full Text] [Related]
11. Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
Baral R; White M; Vassiliou VS
Curr Atheroscler Rep; 2020 Aug; 22(10):61. PubMed ID: 32830286
[TBL] [Abstract][Full Text] [Related]
12. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis.
Zhang X; Yu J; Pan LY; Jiang HY
Pharmacol Res; 2020 Aug; 158():104927. PubMed ID: 32422341
[TBL] [Abstract][Full Text] [Related]
13. The relationship between hyperglycemia and the infection of COVID-19 in diabetic patients: A protocol for systematic review and meta-analysis.
Liu Y; Yang Y; Chen Y; Zhou L; Xiong Q; Xie C
Medicine (Baltimore); 2020 Sep; 99(36):e21806. PubMed ID: 32899010
[TBL] [Abstract][Full Text] [Related]
14. Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis.
Zhou M; Liang Q; Pei Q; Xu F; Wen H
Medicine (Baltimore); 2020 Aug; 99(33):e21034. PubMed ID: 32871977
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
Liu Y; Xie H; Gao H; Xie C
Medicine (Baltimore); 2020 Oct; 99(41):e22592. PubMed ID: 33031311
[TBL] [Abstract][Full Text] [Related]
16. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
[TBL] [Abstract][Full Text] [Related]
17. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review.
Mackey K; King VJ; Gurley S; Kiefer M; Liederbauer E; Vela K; Sonnen P; Kansagara D
Ann Intern Med; 2020 Aug; 173(3):195-203. PubMed ID: 32422062
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine for symptoms of upper respiratory tract of COVID-19: A protocol for systematic review and meta-analysis.
Liang F; Dong L; Zhou L; Shi Y; Tian L
Medicine (Baltimore); 2020 Jul; 99(30):e21320. PubMed ID: 32791725
[TBL] [Abstract][Full Text] [Related]
19. [Effects of angiotensin converting enzyme inhibitor/angiotensin receptor blocker on clinical characteristics of coronavirus disease 2019 patients with hypertension].
Huang W; Li T; Ling Y; Qian ZP; Zhang YY; Huang D; Xu SB; Liu XH; Xia L; Yang Y; Lu SH; Lu HZ
Zhonghua Nei Ke Za Zhi; 2020 Sep; 59(9):689-694. PubMed ID: 32838499
[No Abstract] [Full Text] [Related]
20. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.
Xu J; Huang C; Fan G; Liu Z; Shang L; Zhou F; Wang Y; Yu J; Yang L; Xie K; Huang Z; Huang L; Gu X; Li H; Zhang Y; Wang Y; Hayden FG; Horby PW; Cao B; Wang C
Front Med; 2020 Oct; 14(5):601-612. PubMed ID: 32621202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
